Most patients who are on dialysis require an oral phosphate binder; however, in the absence of robust data from clinical trials, guidelines on the ideal levels of phosphate in these patients are limited. This Review discusses the pharmacology, efficacy and safety of the available phosphate binders, and the problems associated with each binder.
- Alastair J. Hutchison
- Craig P. Smith
- Paul E. C. Brenchley
